Additional file 3: of ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration

Table of qRT-PCR Primer Sequences. Histopathological information on adenoma samples and matching normal mucosa. Age ranges of patients 57–79. Samples listed in order from top to bottom in Fig 2F. (TXT 552 bytes

Self-reported side effects—First report of any grade of side effect during treatment.

<p>Self-reported side effects—First report of any grade of side effect during treatment.</p

Additional file 1: of ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration

COBRA of CRC cell lines showing methylation in majority of samples. COBRA assays on 31 colorectal cancer cell lines reveals that 26 of the cell lines possessed some level of ROR2 methylation. (EPS 3931 kb

Demographic and clinical characteristics of the Elements of Cancer Care cohort.

<p>Demographic and clinical characteristics of the Elements of Cancer Care cohort.</p

Self-reported side effects—Worst grade reported during Elements of Cancer Care study period.

<p>Self-reported side effects—Worst grade reported during Elements of Cancer Care study period.</p

Cumulative incidence of self-reported side effects during Elements of Cancer Care study period.

<p>(A) Chest pain, (B) Constipation, (C) Diarrhoea, (D) Dyspnoea, (E) Fatigue, (F) Mucositis, (G) Pain, (H) Rash, (I) Vomiting <b>></b>.</p

Additional file 1 of Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium

Additional file 1